Publications

Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.

Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1

Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.

Zhu D. et al, (2026), Am J Kidney Dis, 87, 564 - 568

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.

Nielsen AB. et al, (2026), JAMA Intern Med, 186, 311 - 320

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet, 407, 689 - 703

Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial.

Bernholm KF. et al, (2026), Eur J Clin Microbiol Infect Dis

Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial.

Espersen C. et al, (2026), J Infect Dis, 233, e89 - e98

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2026), Lancet Infect Dis, 26, 34 - 45

A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.

Johansen ND. et al, (2026), Am Heart J, 291, 186 - 198

Characteristics of Interventional Clinical Trials Registered in ClinicalTrials.gov, 2018-2023

Sullenger RD. et al, (2026), Journal of Clinical and Translational Science

High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.

Bartholdy KV. et al, (2025), J Am Coll Cardiol, 86, 2636 - 2647

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 Trial.

Espersen C. et al, (2025), J Am Coll Cardiol, 86, 2651 - 2655

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.

Johansen ND. et al, (2025), N Engl J Med, 393, 2291 - 2302

Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.

Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926

A Bayesian re-analysis of the DANFLU-1 trial.

Modin D. et al, (2025), Hum Vaccin Immunother, 21

Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.

Herrington WG. et al, (2025), Lancet Diabetes Endocrinol, 13, 1003 - 1014

Cookies on this website

Search results (316)